-
BioTime CEO Explains What Could Happen To Stem Cell Research And The Company Under A New Guard In Washington
Tuesday, November 22, 2016 - 1:05pm | 528Read More...BioTime, Inc. (NYSE: BTX) is a clinical-stage biotechnology company working on regenerative medicine and pluripotent stem cell technologies. Dr. Michael D. West, the original founder of Geron Corporation (NASDAQ: GERN) (and often called “the father of regenerative medicine”) created it...
-
BioTime CEO Shares Updates On Spinal Cord Injury And Dry AMD Therapies
Monday, November 21, 2016 - 4:36pm | 582Read More...BioTime, Inc. (NYSE: BTX) is a clinical-stage biotechnology company focused on regenerative medicine and pluripotent stem cell technologies. It was established by Dr. Michael D. West, the original founder of Geron Corporation (NASDAQ: GERN), who is often called “the father of regenerative...
-
BioTime CEO Explains Stem Cells And How The Company Uses Them
Sunday, November 20, 2016 - 9:03pm | 499Read More...BioTime, Inc. (NYSE: BTX) is a clinical-stage biotechnology company focused on regenerative medicine and pluripotent stem cell technologies. It was established by Dr. Michael D. West, the original founder of Geron Corporation (NASDAQ: GERN), who is often called “the father of regenerative...
